We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hutchmed (china) Limited | LSE:HCM | London | Ordinary Share | KYG4672N1198 | ORD USD0.10 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.00 | -0.37% | 270.00 | 266.00 | 268.00 | 268.00 | 261.00 | 266.00 | 9,140 | 16:35:06 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 838M | 100.78M | - | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
26/1/2016 14:27 | It has fallen heavily on low volumes. It appears technical. Slater Growth is a big holder of this stock. | d40eq6 | |
26/1/2016 14:10 | No smoke without fire | nw99 | |
26/1/2016 14:07 | Strong support at £10 | nw99 | |
26/1/2016 14:07 | Looks awful and its Chinese | nw99 | |
26/1/2016 14:06 | It's purely technical. It broke 25 pounds and dropped in a vacuum to long term solid buying today | montynj | |
26/1/2016 13:56 | No. There was a piece on Bloomberg earlier about how the biotech sector faces increased volatility and a number of IPO's may be pulled. | liam1om | |
26/1/2016 13:45 | Massive drop!!Are we missing any fudging in account ? These are Chinese companies.. | neurolodger | |
26/1/2016 13:39 | This really is wholly unexpected USAListing delay? | nfs | |
26/1/2016 13:34 | Any reason for the massive drop? | hamsterdam | |
26/1/2016 13:07 | Wiped out here loss cut | nw99 | |
26/1/2016 11:27 | Eeeeerrrrr.... aren't you missing a zero off Beigene's IPO price? Why the massive drop here? Comforting that it's on such tiny volume I suppose. | nahoon | |
25/1/2016 12:58 | Beigene's IPO now priced and ready to go $10m Small Company with a very small pipeline HCM IPO nearly ready to go $100m Big Company with a very large, broad and deep pipeline | nerdofsteel | |
24/12/2015 08:35 | NASDAQ IPO $100m due to complete in Jan Phase III drug study commenced Big property compensation recently announced Further drug pipeline milestone payments received and more due | nerdofsteel | |
23/12/2015 11:39 | any reason for this going up recently? | jayson26jay | |
01/12/2015 16:42 | great find thankyou! I notice Beigene's NASDAQ IPO for $100m, running in parallel to our own, and I'm interested to see how well that goes... | nerdofsteel | |
01/12/2015 13:01 | This looks interesting - helps the long term picture; | sspurt | |
30/11/2015 19:03 | no but there is a huge list due NASDAQ listing Shanghai Property compensation and sale circa $90m proceeds Multiple drug pipeline updates | nerdofsteel | |
30/11/2015 16:33 | Big rise at the close, any news? | ouiey1000 | |
23/11/2015 15:09 | thanks miti - I will do that. I am assuming our IPO will be completed by year end and also assume we may raise more than $100m..... | nerdofsteel | |
13/11/2015 17:26 | revised filing with the SEC, all moving along swiftly I bet the bookrunners have A LOT of interest from their institutional Clients There;s nothing the Americans like more than a Biopharma with a big drug pipeline, existing revs and some big Breakthrough candidates. We will have a further masive re-rating inb the next year IMO | nerdofsteel | |
12/11/2015 13:37 | and now 40p down on 91000 shares traded - big volume, and a lot more bought than sold - looking for a big tickup tomorrow. Someone's bagged a big bargain today. | nerdofsteel | |
12/11/2015 09:01 | Interesting - down 80p on 800 shares traded.....! | essential | |
10/11/2015 16:58 | There's a bigger appreciation on the US market of what biotech stocks are all about not to mention that AIM is a pitifully low calibre and poorly regulated market.Does anyone know what sort of NASDAQ listing the company is considering?There are various options from a lightweight OTC Nasdaq listing (a waste of time because in effect it's near matched bargains) to something more prestigious that GW pharmaceutical have.I guess they'll go for a GWPH type listing.If so,that could be very beneficial.Useful quote for placings etc. | steeplejack | |
10/11/2015 14:36 | Hamstersdam - Not sure I understand where you are coming from. What more do you want from a share apart from a rising price and potentially dividend payments....? | essential |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions